Aug. 16 at 7:03 PM
$TELO Once upon a time in 2003 I had purchased 10,000 shares at
$1.03 in INSM, Insmed Inc. At this time they were a startup pharmaceutical company awaiting for FDA approval for a growth hormone drug. Finally, after 4 months of patience their application was approved by the FDA and the market had opened and I sold my stock at
$2.53 for a profit of
$15,000. I was happy with this. Today, 23 years later this same very company has grown up and now traded yesterday at closing price of
$127.80. I wish I still had the original 10,000 shares thinking how much they would be worth today. But not everyone has the patience of Warren Buffett. However, TELO was just given a new price target yesterday by Zacks Small Cap of
$15.50 per share because they see a potential long term outlook that could be worth a lot. This is a road sign for all you investors to look at and make a decision by based upon a drug they are in the early stages of developing. What decision are you going to make with this info?
